Hunter Immunology Overview

  • Founded
  • 2003
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Hunter Immunology General Information


Developer of medicinal drugs intended to treat patient suffering from chronic obstructive pulmonary disease (COPD).

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Primary Office
  • Avalon Parade 61
  • Sydney, New South Wales 2107
  • Australia
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hunter Immunology Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hunter Immunology‘s full profile, request access.

Request a free trial

Hunter Immunology Executive Team (1)

Name Title Board Seat Contact Info
David Radford Chief Executive Officer
To view Hunter Immunology’s complete executive team members history, request access »